Influence
April 7, 2022

Regenstrief expert helps identify implementation strategies to improve cirrhosis care

The impact on the field of implementation science by Regenstrief Institute Research Scientist Edward J. Miech, EdD, continues to grow.

A study co-authored by Dr. Miech, “Core implementation strategies for improving cirrhosis care in the Veterans Health Administration,” was published in Hepatology. Dr. Miech notes that being published in a journal of this magnitude brings implementation science to a wider audience.

The study evaluated a novel cirrhosis care quality improvement program aimed at identifying implementation strategies associated with improved cirrhosis care over time. The use of configurational analysis identified multiple strategic pathways directly linked to more effective cirrhosis care. Eight implementation strategy combinations were found to be core to cirrhosis care improvement.

The study also used qualitative interviews to operationalize strategies for a manualized intervention. This multi-method approach offers a guide for determining pathways to high-quality care, by selecting efficient and effective implementation strategies and strategy combinations.

In addition to his role as a research scientist at Regenstrief, Dr. Miech is a core investigator for the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center. He also serves as an implementation scientist with the Expanding Expertise Through E-health Network Development Quality Enhance Research Initiative Center based in Indianapolis and is an assistant professor of emergency medicine at Indiana University School of Medicine.

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher